TAVR as Anti-Inflammatory? An effect few imagined

We never saw it coming, such a pleiotropic effect: who would have though a mechanical device could have such a systemic anti-inflammatory effect? Transcatheter aortic valve replacement (TAVR) does in fact have it. 

TAVI como antiinflamatorio

The shear stress aortic stenosis produces activates multiple inflammatory responses mediated by monocytes. This study identified the most important mechanoreceptor, involved in the inflammatory cascade called Piezo-1. This receptor is a potentially druggable target, and although we have not yet been able to block it, we can prevent it from increasing inflammation by lowering shear stress with TAVR. 

The chance of aortic stenosis accelerating or provoking inflammation per se was unknown until now. 

TAVR has given us the unique opportunity to compare the activation status of monocytes under high shear stress (before TAVR) and under low shear stress (after TAVR).

The activation status of monocytes was determined using MAN-1 antibodies, which are specific for the activated B2 integrin Mac-1.


Read also: Computerized Tomography as First Coronary Study?


Activated monocytes adhere to stimulated endothelial cells, phagocytic activity, oxidized low density lipoproteins and cytokine expression. 

Different assays were carried out to collect this information before and after TAVR.

After TAVR, shear stress was reduced, with the resulting reduction of Mac-1 activity, cell adhesion, low density lipoprotein oxidation and inflammatory marker expression in the circulating monocytes. 


Read also: Considerations for Optimal Device Selection in TAVR.


Researchers also observed in the lab, under strictly controlled conditions, that shear stress-dependent calcium influx and monocyte adhesion are mediated by the mechanosensitive ion channel Piezo-1. 

Expression of this receptor depends on shear stress and it clearly drops after TAVR.

Conclusion

This study shows that shear stress produced by diseases such as severe aortic stenosis activates multiple monocyte functions mediated by the mechanosensitive Piezo-1. It also shows the anti-inflammatory effect of TAVR and therefore its new and unknow therapeutic benefit. 

CIRCULATIONA-A-120-045536

Original Title: Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress–Induced, Piezo-1–Mediated Monocyte Activation.

Reference: Sara Baratchi et al. Circulation. 2020;142:1092–1105.  DOI: 10.1161/CIRCULATIONAHA.120.045536.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...